Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC

BACKGROUND: Among advanced non-small cell lung cancer (NSCLC) patients with an acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKI), about 50% carry the T790M mutation, but this frequency in EGFR-TKI-naïve patients and dynamic change during therapy remains un...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhijie, Chen, Rui, Wang, Shuhang, Zhong, Jia, Wu, Meina, Zhao, Jun, Duan, Jianchun, Zhuo, Minglei, An, Tongtong, Wang, Yuyan, Bai, Hua, Wang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236040/
https://www.ncbi.nlm.nih.gov/pubmed/25405807
http://dx.doi.org/10.1371/journal.pone.0110780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236040/
https://www.ncbi.nlm.nih.gov/pubmed/25405807
http://dx.doi.org/10.1371/journal.pone.0110780

Ejemplares similares